Equities

QDM International Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
QDMI:QBB

QDM International Inc

Actions
  • Price (USD)45.33
  • Today's Change0.00 / 0.00%
  • Shares traded3.00
  • 1 Year change-7.73%
  • Beta--
Data delayed at least 15 minutes, as of Jan 28 2026 14:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

QDM International Inc, formerly 24/7 Kid Doc Inc, is a telemedicine company that offers telemedicine access to K-12 schools at no cost to those schools and bill the patient’s insurance or Medicaid for the consultation. The Company provides Connect-a-Doc telemedicine kits to schools. The telemedicine kits generally include digital otoscope, stethoscope, blood pressure cuff, dental camera and dermatology camera. The Company provides services which include acute illness or injury care, dermatology examinations of rashes and lesions, diagnosis and recommendations as to treatment or referral, administering scheduled medications, prescribing non-narcotic medications via e-prescription directly to the student’s designated pharmacy, mental health counseling for depression, drug abuse, and family problems and consulting with staff regarding eating disorders and other behavior issues.

  • Revenue in USD (TTM)13.95m
  • Net income in USD4.96m
  • Incorporated2020
  • Employees9.00
  • Location
    QDM International IncRoom 1030B 10F Ocean Centre Harbour City5 Canton Road, Tsim Sha TsuiSHANGHAI 200051Hong KongHKG
  • Phone+852 34886893
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oncology Institute Inc461.04m-54.66m261.69m825.00------0.5676-0.643-0.6435.37-0.12582.6927.108.08558,835.10-38.67-20.19-57.52-24.6814.8217.89-14.38-12.701.39-3.271.19--21.3320.4121.91--25.76--
Viemed Healthcare Inc254.79m13.61m317.83m1.18k25.212.387.671.250.33160.33166.203.511.3722.409.36216,110.307.5210.849.7313.4957.8960.945.498.631.0118.030.1350.0022.5422.829.985.7323.06--
Burning Rock Biotech Ltd (ADR)78.07m-17.55m318.00m674.00--4.00--4.07-1.68-1.687.327.390.60022.412.79115,823.90-13.50-37.64-18.61-45.8173.0269.83-22.48-124.322.91--0.0036---4.026.2146.97---33.43--
QDM International Inc13.95m4.96m391.39m9.0078.3839.4578.3628.060.57840.57841.631.151.34--23.191,549,779.0047.60--68.92--54.82--35.55----1,015.150.00--31.65--208.29------
Community Health Systems Inc12.64bn329.00m476.51m60.00k1.42--0.50910.03772.432.4394.47-10.720.93166.056.02210,733.303.601.074.491.3484.7883.873.861.311.321.331.100.001.15-0.8877-287.97---3.85--
Charming Medical Ltd6.22m1.20m497.22m49.00414.6810,097.79339.9779.920.07080.07080.36730.0029------126,974.50--------99.75--19.27--0.675--0.8968--3.43--54.16------
Enhabit Inc1.05bn-11.90m571.35m10.70k--1.0137.340.5453-0.2476-0.247620.6011.200.8275--6.9997,925.23-0.7976---0.9216--48.9850.47-0.9639-1.55--1.350.4371---1.10-1.07-94.04---20.68--
Data as of Jan 28 2026. Currency figures normalised to QDM International Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.